ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Geriatric Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,711Medicare Part D Prescriptions Filled, Including Refills

Rank: 27 out of 104

$628K Total Retail Price of All Prescriptions

Rank: 23 out of 104

425 Patients Receiving at Least One Drug in Part D
92% Patients 65 Years and Older
70% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in Michigan
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

4% of this provider’s 425 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

10% of this provider’s 425 patients filled at least one prescription for a schedule three drug, compared to an average of 18%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$65 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

23 is the average number of prescriptions (including refills) per patient, compared to an average of 19.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in Michigan
NAMENDA 535 523 47 1 15
LEVOTHYROXINE SODIUM 490 473 68 2 2
OMEPRAZOLE 416 393 71 3 7
POLYETHYLENE GLYCOL 3350 413 396 46 4 39
AMLODIPINE BESYLATE 296 291* 44 5 6
LISINOPRIL 252 247* 40 6 3
HYDROCODONE-ACETAMINOPHEN 244 226 40 S3 7 1
MIRTAZAPINE 241 241 39 8 26
FUROSEMIDE 227 222* 44 9 5
DONEPEZIL HCL 194 194 26 10 12
ESCITALOPRAM OXALATE 193 175 24 11 27
METOPROLOL TARTRATE 186 181* 33 12 8
METOPROLOL SUCCINATE 176 159 25 13 22
WARFARIN SODIUM 165 146 21 14 9
CLOPIDOGREL 163 158* 22 15 17
ATENOLOL 161 156* 22 16 23
BUMETANIDE 147 147 19 17 54
SERTRALINE HCL 143 130 27 18 20
SIMVASTATIN 132 120 25 19 4
ISOSORBIDE MONONITRATE ER 130 119 18 20 29
LANTUS 124 119* 18 21 45
CALCITONIN-SALMON 124 119* 22 21 207
GABAPENTIN 117 112* 17 23 13
QUETIAPINE FUMARATE 117 117 14 A 23 32
EXELON 114 114 18 25 97
SEROQUEL XR 100 95* 11 A 26 179
LEVETIRACETAM 100 95* 13 26 62
TAMSULOSIN HCL 98 98 14 28 30
KLOR-CON M20 92 92 16 29 88
CITALOPRAM HBR 91 86* 21 30 14
LACTULOSE 83 <11 <11 31 67
LATANOPROST 83 83 15 31 92
PRAMIPEXOLE DIHYDROCHLORIDE 78 <11 <11 33 147
HYDROCHLOROTHIAZIDE 77 77 12 34 19
ZIPRASIDONE HCL 74 <11 <11 A 35 237
LORAZEPAM 73 68* 14 B 36 28
ADVAIR DISKUS 73 <11 <11 36 42
SPIRIVA 72 67* 11 38 51
NYSTOP 71 <11 <11 39 94
KLOR-CON 10 70 <11 <11 40 166
LOSARTAN POTASSIUM 65 60* 11 41 24
TRAMADOL HCL 62 62 13 42 21
ALLOPURINOL 61 <11 <11 43 43
DIVALPROEX SODIUM 59 <11 <11 44 49
METFORMIN HCL 58 <11 <11 45 16
PANTOPRAZOLE SODIUM 56 <11 <11 46 33
TRAZODONE HCL 54 49* 12 47 41
BACLOFEN 51 <11 <11 48 66
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 27, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.